Fubon Financial: Announcement on behalf of Fubon Life Insurance Intending to Participate in the Initial Public Offering of Ordinary Shares of Space Exploration Technologies Corp. (Supplement to 1150609 Announcement)

Fubon Financial, on behalf of its life insurance arm, intends to participate in the IPO of Space Exploration Technologies Corp. by subscribing for 50,000 ordinary shares at USD 135 per share, representing a total transaction amount of USD 6,750,000 (excluding transaction commissions and other related taxes and fees). The investment is for life insurance fund management purposes, and the holding ratio is approximately 0.0007%.
資金調達出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: June 12, 2026 at 09:00
  • 🔍 Collected: June 14, 2026 at 17:00 (56h 0m after Published)
  • 🤖 AI Analyzed: June 14, 2026 at 17:07 (7 min after Collected)
1. Name and nature of the target (if preferred shares, specify issuance conditions such as dividend rate):
Ordinary shares of Space Exploration Technologies Corp.

2. Date of the event:
115/6/12 to 115/6/12.

3. Board approval date:
Not applicable.

4. Other approval dates:
Approval level: Chairman approval.
June 9, 115 (ROC calendar).

5. Number of units, price per unit and total transaction amount:
50,000 shares, USD 135 per share, total transaction amount USD 6,750,000 (excluding transaction commissions and other related taxes and fees).
(Update to the announcement on 115/6/9; the original announcement indicated a subscription cap of USD 600,000,000 (excluding transaction commissions and other related taxes and fees).)

6. Transaction counterparty and its relationship with the company (if the counterparty is a natural person and not a related party, name disclosure may be omitted):
Space Exploration Technologies Corp.; no relationship.

7. If the counterparty is a related party, disclose reasons for selecting the related party as counterparty, prior transfer owners, relationships, prior transfer dates and amounts:
Not applicable.

8. If the target has had owners who were related parties in the past five years, disclose acquisition/disposition dates, prices and relationships at the time:
Not applicable.

9. If this is a disposition of claims (including types of collateral), disclose related matters (if claims are against related parties, disclose names and book amounts):
Not applicable.

10. Disposal gains (or losses) (not applicable for acquisition of securities):
Not applicable.

11. Delivery or payment terms (including payment period and amounts), contractual restrictive clauses and other important agreed terms:
Delivery or payment terms: one-time lump-sum payment.
Contractual restrictive clauses and other important agreed terms: none.

12. Method of decision for this transaction, reference basis for price determination and decision-making unit:
Method and price reference: determined by the issuing company based on demand conditions.
Decision-making unit: according to the company's approval authority.

13. Net asset value per share of the target company of the securities to be acquired or disposed:
NTD 248.30 per share.

14. Accumulated holdings to date (including this transaction): number, amount, holding ratio and any rights restrictions (e.g., pledges):
Financial holding company: none.
Life insurance: 50,000 shares, USD 6,750,000 (excluding transaction commissions and other related taxes and fees), approx. 0.0007%, no rights restrictions.
(Updated from 115/6/9 announcement; the original notice stated that quantity and holding ratio would be announced after confirmation, with a subscription cap of USD 600,000,000 (excluding fees). No rights restrictions.)

15. Proportion of this and other securities investments listed in Article 3 of the Rules Governing Acquisition or Disposal of Assets by Public Companies to total assets and parent's equity in the most recent financial statements, and the amount of operating funds in the most recent financial statements:
Life insurance proportion: 80.25% (updated), 743.75% (updated), not applicable.
Financial holding proportion: 380.13% (updated), 459.91% (updated), not applicable.

16. Broker and brokerage fees:
Goldman Sachs International (updated), USD 0 (updated).

17. Specific purpose or use of the acquisition or disposition:
For the utilization of life insurance funds in accordance with insurance law.

18. Dissenting directors' opinions on this transaction:
Not applicable.

19. Is this a related party transaction:
No.

20. Date of supervisory approval or audit committee consent:
Not applicable.

21. Did the accountant issue an unreasonable opinion:
No.

22. Name of accounting firm:
Hong Wei Certified Public Accountants (宏維會計師事務所).

23. Accountant's name:
Lai Jia-Yi (賴佳誼).

24. Accountant license number:
Tai Cai Zheng Deng (6) No. 4408.

25. Does this involve a change in business model:
No.

26. Explanation of business model change:
Not applicable.

27. Past year and anticipated transactions with the counterparty in the coming year:
Past year: none.
Next year: will depend on market conditions and company strategy.

28. Source of funds:
Own funds.

29. Dates of previously released major information on the same matter:
June 9, 115 (ROC calendar).

30. Other statements:
Supplementary announcements will be made based on allocation results.

Keywords: Major Information

FAQ

What is the purpose of this investment?

It is for the management of life insurance funds under applicable insurance law, aiming to improve investment returns while meeting policyholder obligations.

What are the payment terms?

Payment is a one-time lump sum, and there are no special contractual restrictions or important covenants reported.

Who is the broker and what are the fees?

The broker is Goldman Sachs International (updated). The updated notice reports brokerage fees as 0 USD for this transaction.

What is the holding ratio and are there restrictions?

The life insurance entity will hold 50,000 shares, about 0.0007%, with no rights restrictions reported at present.

Where can I find further disclosures?

Fubon Financial will issue supplementary announcements based on allocation results; follow subsequent filings for details.